₹ 1,576.30
-14.40 (-0.91%)
A
Aurobindo Pharma
₹ 1,576.30
AUROPHARMA Fundamentals
Company Valuation
Market Cap (₹ Cr.)
90,697
PE Ratio
26.40
PB Ratio
2.44
Dividend Yield
0.25%
ROE
10.67%
ROCE
15.74%
Book Value (₹)
652.39
Face Value (₹)
1.00
Analyse AUROPHARMA with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Promoters | 51.82% | 51.82% | 51.82% | 51.82% | 51.88% |
| Domestic Institutional Investors (DII) | 26.93% | 27.60% | 27.68% | 25.87% | 25.10% |
| Foreign Institutional Investors (FII) | 14.37% | 14.21% | 13.94% | 15.24% | 16.38% |
| Public Investors | 5.67% | 5.25% | 5.36% | 5.74% | 5.36% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
AUROPHARMA Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Midcap
BSE Scrip Code
524804
NSE Scrip Name
AUROPHARMA
ISIN
INE406A01037



